Related Experiment Video
Updated: Oct 13, 2025

Isolation and Adoptive Transfer of High Salt Treated Antigen-presenting Dendritic Cells
Published on: March 5, 2019
Clinical Characteristics and Inflammatory Immune Responses in COVID-19 Patients With Hypertension: A Retrospective
Chaoran Wu1, Guangbo Qu2, Lei Wang1
1Department of Cardiology, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
Insights
Hypertension increases COVID-19 severity and organ damage. However, long-term use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) may mitigate these risks in hypertensive COVID-19 patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Pharmacology
Background:
- Cardiovascular and metabolic disorders increase COVID-19 severity and mortality.
- The impact of hypertension and related medications (ACEI/ARB) on COVID-19 clinical outcomes remains unclear.
Purpose of the Study:
- To investigate the clinical characteristics and inflammatory responses in COVID-19 patients with hypertension.
- To evaluate the association between hypertension, ACEI/ARB use, and COVID-19 severity.
Main Methods:
- 90 COVID-19 patients were categorized into hypertension and non-hypertension groups.
- Hypertensive patients were further classified by blood pressure control and ACEI/ARB use.
- Clinical data and inflammatory biomarkers were compared across groups.
Main Results:
- Hypertensive patients showed higher AST and hs-cTnI levels.
- Long-term ACEI/ARB use was associated with lower AST, LDL-C, white blood cell count, and inflammatory markers (though not always statistically significant).
- Hypertensive COVID-19 patients not on ACEI/ARB had a significantly higher risk of severe disease.
Conclusions:
- Hypertension can lead to organ damage in COVID-19 patients.
- Long-term ACEI/ARB treatment may offer protective benefits against COVID-19 severity and organ injury in hypertensive individuals.
Abstract:
Coronavirus disease (COVID-19) patients with cardiovascular and metabolic disorders have been found to have a high risk of developing severe conditions with high mortality, further affecting the prognosis of COVID-19. However, the effect of hypertension and angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blocker (ARB) agents on the clinical characteristics and inflammatory immune responses in COVID-19 patients is still undefined. In this study, 90 COVID-19 patients were divided into hypertension and nonhypertension groups. The hypertension group was divided into well-controlled and poorly controlled subgroups based on blood pressure levels; moreover, hypertensive patients were also divided into ACEI/ARB and non-ACEI/ARB subgroups according to the administration of ACEI/ARB antihypertensive agents. The clinical characteristics of and inflammatory immune biomarker levels in the different groups of COVID-19 patients were compared, and the association between the combined effect of hypertension with ACEI/ARB antihypertensive agents and the severity of COVID-19 was examined. The results showed that the levels of aminotransferase (AST) and hs-cTnI were higher in the hypertension group compared with the nonhypertension group. The long-term use of ACEI/ARB agents in patients had statistically significantly lower AST, low-density lipoprotein cholesterol (LDL-C), and oxygen uptake and lower white cell count, neutrophil count, and levels of CD4, CD8, CRP, and PCT but without statistical significance. In addition, compared with COVID-19 patients without hypertension, hypertensive patients without the use of ACEI/ARB had a higher risk of developing severity of COVID-19 (for poorly controlled patients: OR = 3.97, 95% CI = 1.03-15.30; for well-controlled patients: OR = 6.48, 95% CI = 1.77-23.81). Hypertension could cause organ damage in COVID-19 patients, but the long-term use of ACEI/ARB agents may be beneficial to alleviate this injury.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Hypertension and Regulation of Blood Pressure
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...

